ABCC7 p.Asp651Asn
[switch to full view]Comments [show]
None has been submitted yet.
PMID: 12913074
[PubMed]
Aznarez I et al: "Characterization of disease-associated mutations affecting an exonic splicing enhancer and two cryptic splice sites in exon 13 of the cystic fibrosis transmembrane conductance regulator gene."
No.
Sentence
Comment
3
We have also determined whether five other CF mutations D648V, D651N, G654S, E664X and T665S located near this putative ESE could lead to aberrant splicing of exon 13.
X
ABCC7 p.Asp651Asn 12913074:3:63
status: NEW100 The D648V (2075A!T) (31), D651N (2083G!A) (32) and G654S (2092A!G) (http://www.genet.sickkids.on.
X
ABCC7 p.Asp651Asn 12913074:100:26
status: NEW125 The minigene carrying the D651N mutation yielded two species of aberrantly spliced products.
X
ABCC7 p.Asp651Asn 12913074:125:26
status: NEW126 Firstly, the G to A substitution responsible for D651N, located 10 nt upstream of the 195-cryptic 30 splice site (Fig. 3A), apparently enhanced the usage of this site (Fig. 3B, lane 5) increasing the ratio of the D195 over the wt transcript by 3-fold (Fig. 3D).
X
ABCC7 p.Asp651Asn 12913074:126:49
status: NEW144 We next investigated the effect of co-transfection of an expression plasmid for SF2/ASF with the minigene reporters containing the D651N, E664X and T665S mutations.
X
ABCC7 p.Asp651Asn 12913074:144:131
status: NEW162 (B) RT-PCR analysis of COS-7 cell lines transfected with minigenes driven by the CMV promoter carrying the wild-type exon 13 sequence, WT, and 2074G!T, D648V, 2076T!A, D651N and G654S mutations separated in a 2% agarose gel.
X
ABCC7 p.Asp651Asn 12913074:162:168
status: NEW176 We have also expanded the search for other relevant sequences to the splicing of exon 13 and analyzed the effect of five additional previously reported CFTR mutations, D648V, D651N, G654S, E664X and T665S.
X
ABCC7 p.Asp651Asn 12913074:176:175
status: NEW203 Minigenes carrying D651N, E664X and T665S mutations were transfected alone (noted by the minus sign) or co-transfected with SF2/ASF (noted by the plus sign).
X
ABCC7 p.Asp651Asn 12913074:203:19
status: NEW212 Conversely, SF2/ASF exacerbated the effect of D651N, E664X and T665S mutations on the splicing of exon 13.
X
ABCC7 p.Asp651Asn 12913074:212:46
status: NEW221 The mutations were reported to associate with CF phenotype [D648V (31), E656X (http:// www.genet.sickkids.on.ca/cftr/), 2108delA (27), E664X (33) and T665S (http://www.genet.sickkids.on.ca/cftr/)] or with pulmonary disease [D651N (32)].
X
ABCC7 p.Asp651Asn 12913074:221:224
status: NEW
PMID: 9921909
[PubMed]
Bombieri C et al: "Complete mutational screening of the CFTR gene in 120 patients with pulmonary disease."
No.
Sentence
Comment
4
Four new mutations were identified: D651N, 2377C/T, E826K, and P1072L.
X
ABCC7 p.Asp651Asn 9921909:4:36
status: NEW63 Three novel mutations were first identified in this study: D651N, E826K, and P1072L.
X
ABCC7 p.Asp651Asn 9921909:63:59
status: NEW73 D651N, a G to A transition was detected at nucleotide 2083 in exon 13, which codes for the regulatory domain of CFTR.
X
ABCC7 p.Asp651Asn 9921909:73:0
status: NEW88 of cases CFTR gene PolyTb status tested mutationa DBE 23 1 G576A-R668C/L997F 7/9 1 ∆F508/L997F 9/9 1 ∆F508/- 7/9 1 R1066C/- 5/7 1 3667ins4/- 5/7 1 R75Q/- 7/7 1 M1137V/- 7/7 1 -/- 5/5 3 -/- 5/7 10 -/- 7/7 2 -/- 7/9 CB 27 1 P111L/- 7/7 1 R117H/- 7/7 1 E585X/- 7/7 1 P1072L/- 7/7 1 -/- 5/7 15 -/- 7/7 6 -/- 7/9 1 -/- 9/9 E 25 1 R668C/- 7/7 6 -/- 5/7 16 -/- 7/7 6 -/- 7/9 S 8 1 E826K/- 7/7 1 ∆F508/- 7/9 1 4382delA/- 7/7 1 L997F/- 7/9 1 V754M/- 7/9 3 -/- 7/7 LC 26 1 I148T/- 5/7 1 D1270N-R74W 5/7 1 D651N/- 7/7 1 Y301C/- 7/7 1 -/- 5/7 16 -/- 7/7 5 -/- 7/9 TB 4 1 -/- 5/7 1 -/- 7/7 2 -/- 7/9 Pneumonia 5 4 -/- 7/7 1 -/- 5/7 Pnx 2 2 -/- 7/7 Controls 68 1 L997F/- 7/9 1 R31C/- 7/7 1 I506V/- 5/7 1 -/- 5/7 1 -/- 5/9 23 -/- 7/7 4 -/- 7/9 1 -/- 9/9 2 ?
X
ABCC7 p.Asp651Asn 9921909:88:516
status: NEW
PMID: 11001817
[PubMed]
Chen JM et al: "Definition of a "functional R domain" of the cystic fibrosis transmembrane conductance regulator."
No.
Sentence
Comment
32
Another missense mutation D651N that changes a conserved, negatively charged residue was reported to be a neutral polymorphism (11).
X
ABCC7 p.Asp651Asn 11001817:32:26
status: NEW